SpectraFluidics and U.S. Army Expand Partnership
Chemical detection company signs three-year contract to provide advanced handheld explosive detector technology.
The three-year contract between SpectraFluidics, UC Santa Barbara’s Institute for Collaborative Biotechnologies (ICB) and the U.S. Army’s Edgewood Chemical Biological Center builds on the partnership begun in 2008, under which SpectraFluidics first developed and proved its advanced, chemical detection technology for explosives and biohazards. This new agreement allows for further development of the detector device.
“Detection of Improvised Explosive Devices is one of the Army’s most pressing issues,” says
The proposed lightweight, portable device combines free-surface microfluidics and nanoparticle techniques with surface-enhanced Raman spectroscopy (SERS). Other technologies on the market cannot be easily reduced in size without suffering significant performance degradation.
The SpectraFluidics patented technology allows for the direct detection of trace levels of airborne explosives with minimal user interaction. Ultimately, the device will provide unparalleled, real-time sampling and detection of trace amounts of explosives in either vapor phase or condensed media phase.
“Our novel microfluidic/SERS device allows us to overcome the limitations of previous Raman systems aimed at explosives detection, resulting in significant improvement in detection sensitivity, selectivity and specificity,” says
SpectraFluidics Inc. is a privately owned corporation focused on the development of advanced technologies for the field detection of trace levels of explosives, illicit drugs and other contraband. SpectraFluidics’ primary offices and laboratories are located in the Storke-Hollister Research Center in
SOURCE SpectraFluidics Inc.